Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Perion to Participate in the 28th Annual Needham Growth Conference on January 14th, 2026
-
L3Harris to Sell Majority Stake in Space Propulsion & Power Business to AE Industrial Partners
-
Kelun-Biotech Receives Investigational New Drug Approval for ITGB6-Targeted ADC SKB105 from the NMPA
-
SBC Medical Accelerates Global Expansion with Strategic Investment and Alliance with a Leading U.S. MedSpa Platform OrangeTwist as Part of Broader Growth Strategy
-
Seeing Machines to unveil 3D Cabin Perception Mapping at CES2026
-
Comcast Announces Completion of Separation of Versant Media Group, Inc.
-
Takeda and Protagonist Announce Submission of New Drug Application (NDA) for Rusfertide for Treatment of Polycythemia Vera (PV)
-
NaaS Technology Inc. to Hold Extraordinary General Meeting on January 23, 2026
-
Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
ProtoArc to Debut Smart Workspace Concept at CES 2026
-
Cellarity to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Evergold Announces $300,000 Ore Group Financing, Sharpened Focus on Golden Lion Project, Toodoggone District, Northern BC
-
Sibros Launches SDV App Marketplace, Bringing Turnkey Connected Solutions to Automakers and Fleets
-
Seaport Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
-
United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference
-
Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.
-
IntBot to Debut First-Ever Unmanned CES Booth Run by a Robot; Humanoid "Nylo" Takes the Floor Solo
-
cliexa Announces cliexaAI – Opioid Use Disorder (OUD) Solution Is Now a Qualified Solution on Mayo Clinic Platform
-
CareTrust Announces Promotions and Key Hires
-
Majestic Steel USA Strengthens Executive Leadership, Naming Chad Broyles EVP of Business Operations
-
Zephr’s New Positioning SDK Brings Sub-Meter Precision to Android Devices – Laying the Groundwork for Location-Aware AI
-
Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
ShipBob Surpasses 1 Billion Units Fulfilled, Sets New Black Friday/Cyber Monday Records as Brands Scale Across Channels
-
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morg
-
Everspin Technologies to Present at the Needham Growth Conference
-
Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Crescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific Antibody and CR-003, an ITGB6-targeted ADC, for the Treatment of Solid Tumors
-
MAYFLOWER WELCOMES BMS MOVING & STORAGE TO THE NETWORK, FURTHER STRENGTHENING ITS NATIONWIDE SERVICE
-
Mobilicom Announces New Design Win and Initial Order from United Arab Emirates–Based Arms Manufacturer
-
OKYO Pharma Appoints Industry Veteran Robert J. Dempsey as Chief Executive Officer
-
Mobix Labs Powers Up U.S. Defense Operations: Veteran Defense GM Takes the Helm; Bigger Military-Approved Facility Expansion Planned
-
Beamr 2026 Strategy and 2025 Highlights
-
UMH PROPERTIES, INC. FOURTH QUARTER AND FULL YEAR 2025 OPERATIONS UPDATE
-
Gyre Therapeutics Announces Alignment with China’s CDE on Conditional Approval Pathway and Priority Review Eligibility for Hydronidone Following Pre-NDA Meeting
-
Enhance Your Dry January with Mindful Sipping: Try Tilray’s Mollo and XMG Cannabis Beverages
-
Cibus and Interoc Advance Rice Commercialization Strategy for Herbicide-Tolerant Traits in Key Markets across Latin America
-
MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer’s Disease Psychosis
-
Gogo issues year-end “report card” on critical new product initiatives.
-
Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer
-
Upstream Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Seyond to Showcase Live RoboVan Demonstrations and Next-Generation LiDAR at CES 2026
-
Orion Group Holdings Awarded $86.3 Million U.S. Army Corps of Engineers Project
-
ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026
-
Fractyl Health Enters a Catalyst-Rich 2026 Positioned to Define the Post-GLP-1 Weight Maintenance Therapeutic Category
-
OTC Markets Group Welcomes FPX Nickel Corp. to OTCQX
-
Frontier Medicines Announces Publication in Nature Communications Highlighting a Novel Method that Enables Next-Generation Covalent Medicines
-
Apellis Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Olema Oncology to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

